SCHEMBL668702

SCHEMBL668702

NC(=O)c1ccccc1CCS(N)(=O)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 3/20 0.47
HPGD P15428 2/20 0.47
HSD17B10 Q99714 2/20 0.47
MAPT P10636 1/20 0.47
TSHR P16473 1/20 0.47
METAP2 P50579 1/20 0.44
FOLH1 Q04609 1/20 0.41
KMT2A Q03164 2/20 0.39
BCAT2 O15382 1/20 0.39
CA1 P00915 4/20 0.39
CA2 P00918 4/20 0.39
CA9 Q16790 4/20 0.39
CA12 O43570 2/20 0.39
CA3 P07451 2/20 0.39
CA4 P22748 2/20 0.39
CA6 P23280 2/20 0.39
CA7 P43166 2/20 0.39
CA13 Q8N1Q1 2/20 0.39
CA14 Q9ULX7 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4735612 0.87 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL4564260 0.84 IKBKB (0.52) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL2854688 0.81 KDM4E (0.50) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL9843838 0.80 ALDH1A1 (0.60) ALDH1A1KDM4EHSD17B10TSHRKMT2A
SCHEMBL30177551 0.79 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL940131 0.78 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTTSHRFOLH1
SCHEMBL25435653 0.77 TAAR1 (0.57) TSHRCA1CA2CA9CA12
SCHEMBL31054164 0.77 MAPT (0.48) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL363595 0.77 BCAT2 (0.48) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL731621 0.77 HMGB1 (0.55) ALDH1A1KDM4EHPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606038-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2013-06-26 EP disclosed
WO-2012024373-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-23 WO disclosed